Ana-Maria Buruiana

Ms. Ana-Maria Buruiana


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu
OROlivia Verisezan Rosu
Olivia Verisezan Rosu
NJNicoleta Jemna
Nicoleta Jemna
IBIrina Benedek
Irina Benedek
JRJulia Rednic
Julia Rednic
SSStefan Strilciuc
Stefan Strilciuc
Background: Cognitive deficits following ischemic stroke significantly impair quality of life, highlighting the need for effective interventions. This study evaluates the efficacy and safety of extended N-Pep-12 dietary supplementation in enhancing cognitive recovery post-stroke. Methods: In this randomized, open-label, controlled study, 106 patients with supratentorial ischemic stroke were enrolled to receive either 90mg N-Pep-12 or no supplementation daily for 360 days and were followed-up for 360 days. Cognitive function and emotional well-being were assessed using established neuropsychological scales at baseline, 90 days, and 360 days post-stroke. Safety was monitored through adverse events and mortality rates. Results: Significant improvements were observed in the N-Pep-12 group compared to controls, particularly in the Montreal Cognitive Assessment scores at both 90 and 360 days, and in the Digit Symbol Coding scores at 360 days, suggesting enhanced cognitive recovery with extended N-Pep-12 supplementation. A linear regression for a composite outcome analysis at day 360 further confirmed the efficacy of N-Pep-12 in contributing to cognitive improvement. Safety profiles were favorable, with no significant adverse effects attributed to N-Pep-12. Conclusions: Extended dietary supplementation with N-Pep-12 appears to offer a safe and effective approach to support cognitive recovery in ischemic stroke survivors. These findings underscore the potential of the supplement as an add-on intervention for managing post-stroke cognitive impairments.

21 August 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
DCDiana Chira
Diana Chira
NJNicoleta Jemna
Nicoleta Jemna
OROlivia Verisezan Rosu
Olivia Verisezan Rosu
ABAna-Maria Buruiana
Ana-Maria Buruiana
SSStefan Strilciuc
Stefan Strilciuc
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu
Background: Subjective cognitive complaints (SCCs) are common in middle-aged and older adults and may reflect early cognitive changes, alongside alterations in stress, mood, sleep, and quality of life. N-PEP-12 is a peptide-based nutritional supplement with potential neuroprotective effects, but evidence of its benefits in healthy adults with SCCs remains limited. Objective: To evaluate the effects of N-PEP-12 supplementation on attention, cognitive function, and mental wellbeing in healthy middle-aged and older adults with SCCs. Methods: In this prospective, randomized, double-blind, placebo-controlled trial, 276 participants aged 50–75 years with SCCs and no clinically significant cognitive impairment were randomized to placebo, N-PEP-12 45 mg, or N-PEP-12 90 mg. Assessments were performed at baseline and after 30, 90, and 180 days. Primary outcomes included Test of Attentional Performance measures. Secondary outcomes included WAIS-IV Digit Span Forward and Backward, perceived stress, mood, sleep quality, and EQ-5D-5L visual analog scale. Results: Across the three primary attention outcomes analyzed jointly in a multivariate repeated-measures model, there was a significant group-by-visit interaction (p = 0.003) and a significant effect of visit (p < 0.001), without a significant main effect of treatment arm (p = 0.133), indicating a time-dependent treatment effect. This result was obtained in a sensitivity analysis population in which missing values were imputed under assumptions least favorable to the active arms. In exploratory endpoint-specific comparisons at 90 days, both N-PEP-12 groups showed greater improvements than placebo in alertness, attention omissions and memory omissions, and Digit Span Forward and Backward scores also improved. In a subsequent uncontrolled extension phase, in which all participants received active treatment, participants initially assigned to placebo showed comparable improvements after switching to N-PEP-12 90 mg. These observations are exploratory. Adverse events were infrequent and similarly distributed across groups. Conclusions: N-PEP-12 supplementation was associated with improvements in attention, working memory, and mental wellbeing in healthy middle-aged and older adults with subjective cognitive complaints. These findings support further investigation of N-PEP-12 as a nutritional intervention for early subjective cognitive changes associated with aging.

27 September 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
DCDiana Chira
Diana Chira
OROlivia Verisezan Rosu
Olivia Verisezan Rosu
SSStefan Strilciuc
Stefan Strilciuc
NJNicoleta Jemna
Nicoleta Jemna
ABAna-Maria Buruiana
Ana-Maria Buruiana
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu
Background: Subjective cognitive complaints (SCCs) in middle-aged and older adults are recognized as early warning signs of future cognitive decline. While biological risk factors have been studied extensively, less is known about how modifiable lifestyle factors, stress, mood and sleep relate to actual performance on cognitive tests. Objective: To examine associations between lifestyle (physical activity, alcohol consumption), psychosocial factors (perceived stress, mood, sleep) and standardized cognitive performance in adults with SCCs. Methods: We conducted a cross-sectional analysis using baseline data from 276 adults aged 50–75 years enrolled in the N-HANCE study. Participants completed the Test of Attentional Performance (TAP) and Digit Span (Forward and Backward). Lifestyle and psychosocial variables were assessed using structured questions and validated self-report scales. Associations were examined using Spearman correlations and Mann–Whitney U tests, with Benjamini–Hochberg correction applied across the full family of 132 predictor–outcome comparisons, followed by linear regression models adjusted for age, sex and educational attainment. Results: Educational attainment showed the strongest and most consistent associations, relating to better performance across attention and memory measures assessed (ρ = 0.21 to 0.44, all q < 0.01). Older age was associated with poorer memory span and less consistent alertness. A history of depression was associated with reduced alertness and this association was essentially unchanged after adjustment (β = −0.19, p < 0.001). Higher BMI was associated with poorer memory span (ρ = −0.18; adjusted β = −0.16, p = 0.005) and higher perceived stress with poorer working memory (Digit Span Backward ρ = −0.21; adjusted β = −0.11, p = 0.046; p = 0.062 under robust standard errors). Associations involving mood and sleep quality attenuated to non-significance after adjustment, while physical activity retained only a marginal association with divided attention. Nineteen of 132 associations survived correction for multiple comparisons. Conclusions: In adults with SCCs, educational attainment and age, a proxy of cognitive reserve and an index of aging respectively, rather than modifiable targets, accounted for the strongest associations with objective cognitive performance. Among potentially modifiable factors, a history of depression and higher BMI showed the most robust independent associations, while associations with mood and sleep did not persist after adjustment and physical activity retained only a marginal association. These cross-sectional findings identify candidate risk and resilience markers that require confirmation in longitudinal follow-up.